2565 — Pegbio Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$5.06bn
- HK$4.57bn
Annual cashflow statement for Pegbio Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -279 | -283 | -209 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 29.8 | 142 | 88.3 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 12.4 | -44.6 | -35.4 |
| Change in Other Assets | |||
| Change in Accrued Expenses | |||
| Change in Payable / Accrued Expenses | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -233 | -183 | -152 |
| Capital Expenditures | -0.617 | -1.08 | -3.66 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 102 | 115 | 102 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Sale of Intangible Assets | |||
| Cash from Investing Activities | 102 | 114 | 97.9 |
| Financing Cash Flow Items | 132 | -3.93 | -9.32 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 149 | 20.3 | 499 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 16.9 | -48.8 | 439 |